4.
不同临床分期中基因诊断准确度的比较
Comparison of the accuracy of gene diagnosis in different clinical stages
| Diagnosis index | Ⅰ (n=71) | Ⅱ (n=17) | Ⅲ (n=46) | Ⅳ (n=44) |
| a: Combined diagnosis of CEA, CYFR211, SCC, ProGRP and NSE; b: Combined diagnosis of CDO1, CEA, CYFR211, SCC, ProGRP and NSE. | ||||
| CDO1 | 40.8% | 47.1% | 43.5% | 81.8% |
| CEA | 17.1% | 18.8% | 34.8% | 45.5% |
| CYFR211 | 14.5% | 25.0% | 52.2% | 63.3% |
| SCC | 4.3% | 31.3% | 21.7% | 27.3% |
| ProGRP | 2.9% | 25.0% | 21.7% | 18.2% |
| NSE | 15.9% | 40.0% | 46.7% | 59.1% |
| Five combined checka | 44.9% | 68.8% | 87.0% | 88.6% |
| Six combined checkb | 62.0% | 82.4% | 87.0% | 97.7% |